These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 3924612)

  • 1. Twenty-five year review of Pseudomonas aeruginosa bacteremia in a burn center.
    McManus AT; Mason AD; McManus WF; Pruitt BA
    Eur J Clin Microbiol; 1985 Apr; 4(2):219-23. PubMed ID: 3924612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent bacteremia: A 10-year retrospective study in combat-related burn casualties.
    Aurora A; Le TD; Akers KS; Blyth DM; Graybill JC; Clemens MS; Chung KK; Rizzo JA
    Burns; 2019 May; 45(3):579-588. PubMed ID: 30385059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance of antibiotic susceptibility in a Swedish Burn Center 1994-2012.
    Fransén J; Huss FR; Nilsson LE; Rydell U; Sjöberg F; Hanberger H
    Burns; 2016 Sep; 42(6):1295-303. PubMed ID: 27241732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa bacteremia after burn injury: the impact of multiple-drug resistance.
    Theodorou P; Thamm OC; Perbix W; Phan VT
    J Burn Care Res; 2013; 34(6):649-58. PubMed ID: 23817000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomonas infections in Tohid Burn Center, Iran.
    Rastegar Lari A; Bahrami Honar H; Alaghehbandan R
    Burns; 1998 Nov; 24(7):637-41. PubMed ID: 9882062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of burn mortality and bacteremia. A 25-year review.
    Mason AD; McManus AT; Pruitt BA
    Arch Surg; 1986 Sep; 121(9):1027-31. PubMed ID: 3741098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of pseudomonas aeruginosa in a burn hospital: evaluation of serological, bacteriophage, and pyocin typing methods.
    Edmonds P; Suskind RR; Macmillan BG; Holder IA
    Appl Microbiol; 1972 Aug; 24(2):213-8. PubMed ID: 4627229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemilogy of Pseudomonas in a burn intensive care unit.
    MacMillar BG; Edmonds P; Hummel RP; Maley MP
    J Trauma; 1973 Jul; 13(7):627-38. PubMed ID: 4197546
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence and resistance of Pseudomonas aeruginosa in severely burned patients: a 10-year retrospective study.
    Lipový B; Rihová H; Hanslianová M; Gregorová N; Suchánek I; Brychta P
    Acta Chir Plast; 2010; 52(2-4):39-43. PubMed ID: 21749009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of nosocomially-acquired resistant Pseudomonas aeruginosa infection in a burn unit.
    Armour AD; Shankowsky HA; Swanson T; Lee J; Tredget EE
    J Trauma; 2007 Jul; 63(1):164-71. PubMed ID: 17622885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemic Pseudomonas aeruginosa serotype O16 bacteremia in hematology-oncology patients.
    Richet H; Escande MC; Marie JP; Zittoun R; Lagrange PH
    J Clin Microbiol; 1989 Sep; 27(9):1992-6. PubMed ID: 2506221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The analysis of distribution of multidrug resistant Pseudomonas and Bacillus species from burn patients and burn ward environment.
    Panghal M; Singh K; Kadyan S; Chaudary U; Yadav JP
    Burns; 2015 Jun; 41(4):812-9. PubMed ID: 25468476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local Application of Probiotic Bacteria Prophylaxes against Sepsis and Death Resulting from Burn Wound Infection.
    Argenta A; Satish L; Gallo P; Liu F; Kathju S
    PLoS One; 2016; 11(10):e0165294. PubMed ID: 27780258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocarditis in burn patients: clinical and diagnostic considerations.
    Regules JA; Glasser JS; Wolf SE; Hospenthal DR; Murray CK
    Burns; 2008 Aug; 34(5):610-6. PubMed ID: 18029099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of infections with Pseudomonas aeruginosa in burn patients: the role of hydrotherapy.
    Tredget EE; Shankowsky HA; Joffe AM; Inkson TI; Volpel K; Paranchych W; Kibsey PC; Alton JD; Burke JF
    Clin Infect Dis; 1992 Dec; 15(6):941-9. PubMed ID: 1457665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative pressure wound therapy decreases mortality in a murine model of burn-wound sepsis involving Pseudomonas aeruginosa infection.
    Liu Y; Zhou Q; Wang Y; Liu Z; Dong M; Wang Y; Li X; Hu D
    PLoS One; 2014; 9(2):e90494. PubMed ID: 24587379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proteomic study of peripheral blood lymphocytes of rabbits with severe burn and Pseudomonas aeruginosa sepsis].
    Zeng JZ; Zhang PH; Li LL; Ren LC; Liang PF; Huang XY
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Aug; 21(8):455-9. PubMed ID: 19695163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the soxR gene of Pseudomonas aeruginosa is inducible during infection of burn wounds in mice and is required to cause efficient bacteremia.
    Ha U; Jin S
    Infect Immun; 1999 Oct; 67(10):5324-31. PubMed ID: 10496912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudomonas aeruginosa: a controlled burn pathogen?
    McManus AT
    Antibiot Chemother (1971); 1989; 42():103-8. PubMed ID: 2512832
    [No Abstract]   [Full Text] [Related]  

  • 20. Bacteriological cultures on admission of the burn patient: To do or not to do, that's the question.
    Dokter J; Brusselaers N; Hendriks WD; Boxma H
    Burns; 2016 Mar; 42(2):421-7. PubMed ID: 26777453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.